When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.
Glucocorticoids are widely used in rheumatoid arthritis (RA); however, their effectiveness and safety is still a subject of debate. In particular, when to introduce glucocorticoids, but also when and how to taper them, are important questions for clinicians. In this paper, we will discuss the place of glucocorticoids in the European League Against Rheumatism (EULAR) recommendations for the management of RA and review the literature that was the basis for these recommendations. The recommendations cover the introduction of glucocorticoids (and for whom they are recommended), doses and duration of treatment, and tapering strategies. Items still on the research agenda include more data on safety, particularly for long-term use, and small doses of glucocorticoids.
Department of Rheumatology, Nîmes University Hospital, Montpellier 1 University, Nîmes, France.
Cécile
C
Gaujoux-Viala
Laure
L
Gossec
D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D017410:Practice Guidelines as Topic
D018501:Antirheumatic Agents; D005938:Glucocorticoids
EULAR; glucocorticoids; inflammation; recommendations; rheumatoid arthritis